Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 4
Submit an article Journal homepage
91
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Lack of myeloproliferative neoplasm-associated CALR mutations in acute promyelocytic leukemia

Stephen E. LangabeerCancer Molecular Diagnostics, St. James's Hospital, Dublin, IrelandCorrespondence[email protected]
&
Karl HaslamCancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland
Pages 1168-1169 | Received 23 Jun 2014, Accepted 04 Aug 2014, Published online: 07 Oct 2014

References

  • Kelly LM, Kutok JL, Williams IR, et al. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci USA 2002;99:8283–8288.
  • Le Beau MM, Davis EM, Patel B, et al. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia. Blood 2003;102:1072–1074.
  • Wartman LD, Larson DE, Xiang Z, et al. Sequencing of a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. J Clin Invest 2011;121:1445–1455.
  • Welch JS, Ley TJ, Link DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012;150:264–278.
  • Riva L, Ronchini C, Bodini M, et al. Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups. Blood Cancer J 2013;3:e147.
  • Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013; 369:2379–2390.
  • Nangalia J, Massie CE, Baxter EJ, et al. Somatic CALR mutations in myeloproliferative neoplasms with unmutated JAK2. N Engl J Med 2013;369:2391–2405.
  • COSMIC. Catalogue of somatic mutations in cancer. Available from: http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/
  • Haslam K, Langabeer SE, Molloy K, et al. Assessment of CALR mutations in myelofibrosis patients post-allogeneic stem cell transplantation. Br J Haematol 2014;166:800–802.
  • Gale RE, Hills R, Pizzey AR, et al. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood 2005;106:3768–3776.
  • Breccia M, Loglisci G, Loglisci MG, et al. FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis. Haematologica 2013;98:e161–e163.
  • Batlle M, Fernández-Avilés F, Ribera JM, et al. Acute promyelocytic leukemia in a patient with idiopathic myelofibrosis. Leukemia 1999;13:492–494.
  • Sato N, Furukawa T, Masuko M, et al. Acute promyelocytic leukemia developing in untreated essential thrombocythemia. Am J Hematol 2002;71:114–116.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.